• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Behavioral Activation for Comorbid Depression in People With Noncommunicable Disease in India: Protocol for a Randomized Controlled Feasibility Trial.印度非传染性疾病患者共病抑郁症的行为激活:一项随机对照可行性试验方案
JMIR Res Protoc. 2023 Nov 16;12:e41127. doi: 10.2196/41127.
2
Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.行为激活疗法治疗脑卒中后抑郁:BEADS 可行性 RCT。
Health Technol Assess. 2019 Sep;23(47):1-176. doi: 10.3310/hta23470.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Evaluating the impact of culturally specific patient-centric behavioral intervention package versus usual care for tobacco cessation among patients attending noncommunicable disease clinics in North India: A single-blind trial pilot study protocol.评估针对印度北部非传染性疾病诊所患者的特定文化背景下以患者为中心的行为干预方案与常规戒烟护理的效果:一项单盲试验性研究方案。
Tob Use Insights. 2021 Dec 23;14:1179173X211056622. doi: 10.1177/1179173X211056622. eCollection 2021.
5
Guided self-help for depression in autistic adults: the ADEPT feasibility RCT.孤独症成人抑郁的引导自助:ADEPT 可行性 RCT。
Health Technol Assess. 2019 Dec;23(68):1-94. doi: 10.3310/hta23680.
6
Vitalizing Community for Health Promotion Against Modifiable Risk Factors of Noncommunicable Diseases (V-CaN) in Rural Central India: Protocol for a Hybrid Type II Implementation Effectiveness Trial.印度中部农村地区通过增强社区力量促进健康以应对非传染性疾病可改变风险因素(V-CaN):一项混合型II期实施效果试验方案
JMIR Res Protoc. 2023 Sep 29;12:e42450. doi: 10.2196/42450.
7
Rationale, Design, and Intervention Development of a Mobile Health-Led Primary Care Program for Management of Type 2 Diabetes in Rural Thailand: Protocol for a SMARThealth Diabetes Study.泰国农村地区基于移动医疗的 2 型糖尿病管理的初级保健项目的原理、设计和干预方案开发:SMARThealth Diabetes 研究方案。
JMIR Res Protoc. 2024 Aug 16;13:e59266. doi: 10.2196/59266.
8
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.行为激活(COBRA)的成本和结果:行为激活与认知行为疗法治疗抑郁症的随机对照试验。
Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460.
9
The effectiveness and cost-effectiveness of the peer-delivered Thinking Healthy Programme for perinatal depression in Pakistan and India: the SHARE study protocol for randomised controlled trials.同伴主导的“健康思考计划”对巴基斯坦和印度围产期抑郁症的有效性及成本效益:随机对照试验的SHARE研究方案
Trials. 2015 Nov 25;16:534. doi: 10.1186/s13063-015-1063-9.
10
Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study.针对就诊于性健康诊所的患者的性风险降低干预措施:一项混合方法可行性研究。
Health Technol Assess. 2019 Mar;23(12):1-122. doi: 10.3310/hta23120.

本文引用的文献

1
National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke: A Scoping Review in the Context of Hypertension Prevention and Control in India.国家癌症、糖尿病、心血管疾病和中风预防与控制计划:印度高血压预防与控制背景下的范围综述。
Indian J Public Health. 2023 Jan 1;67(Suppl 1):S50-S57. doi: 10.4103/ijph.ijph_681_23. Epub 2024 Jan 31.
2
Confirmatory factor analysis of the Depression, Anxiety, and Stress Scale among Indian adults.印度成年人抑郁、焦虑和压力量表的验证性因素分析。
Indian J Psychiatry. 2020 Jul-Aug;62(4):379-383. doi: 10.4103/psychiatry.IndianJPsychiatry_313_19. Epub 2020 Jul 27.
3
Integrating depression care within NCD provision in Bangladesh and Pakistan: a qualitative study.在孟加拉国和巴基斯坦的非传染性疾病防治中整合抑郁症护理:一项定性研究。
Int J Ment Health Syst. 2020 Aug 11;14:63. doi: 10.1186/s13033-020-00399-y. eCollection 2020.
4
Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.印度一项针对伴发抑郁和糖尿病患者的随机临床试验(INDEPENDENT)表明,协同护理模式可改善抑郁症状及糖化血红蛋白、血压和血清胆固醇水平。
JAMA. 2020 Aug 18;324(7):651-662. doi: 10.1001/jama.2020.11747.
5
Co-existing Non-communicable Diseases and Mental Illnesses Amongst the Elderly in Punjab, India.印度旁遮普邦老年人中并存的非传染性疾病和精神疾病
Eur Endocrinol. 2019 Aug;15(2):106-112. doi: 10.17925/EE.2019.15.2.106. Epub 2019 Aug 16.
6
Psychological treatments for depression among women experiencing intimate partner violence: findings from a randomized controlled trial for behavioral activation in Goa, India.针对受亲密伴侣暴力困扰的女性抑郁症的心理治疗:印度果阿行为激活随机对照试验的结果。
Arch Womens Ment Health. 2019 Dec;22(6):779-789. doi: 10.1007/s00737-019-00992-2. Epub 2019 Jul 30.
7
Behavior Change Techniques and Their Mechanisms of Action: A Synthesis of Links Described in Published Intervention Literature.行为改变技术及其作用机制:已发表干预文献中描述的联系综合。
Ann Behav Med. 2019 Jul 17;53(8):693-707. doi: 10.1093/abm/kay078.
8
Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial.协作式护理与常规护理对老年亚临床抑郁患者抑郁症状的影响:CASPER 随机临床试验。
JAMA. 2017 Feb 21;317(7):728-737. doi: 10.1001/jama.2017.0130.
9
The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: a randomised controlled trial.健康活动项目(HAP),一种由非专业顾问提供的针对重度抑郁症的简短心理治疗方法,在印度初级保健中的应用:一项随机对照试验。
Lancet. 2017 Jan 14;389(10065):176-185. doi: 10.1016/S0140-6736(16)31589-6. Epub 2016 Dec 15.
10
Discrepancies between qualitative and quantitative evaluation of randomised controlled trial results: achieving clarity through mixed methods triangulation.随机对照试验结果定性与定量评估之间的差异:通过混合方法三角互证实现明晰性
Implement Sci. 2016 May 12;11:66. doi: 10.1186/s13012-016-0436-0.

印度非传染性疾病患者共病抑郁症的行为激活:一项随机对照可行性试验方案

Behavioral Activation for Comorbid Depression in People With Noncommunicable Disease in India: Protocol for a Randomized Controlled Feasibility Trial.

作者信息

Zainab Rayeesa, Kandasamy Arun, Bhat Naseer Ahmad, Dsouza Chrishma Violla, Jennings Hannah, Jackson Cath, Mazumdar Papiya, Hewitt Catherine Elizabeth, Ekers David, Narayanan Gitanjali, Rao Girish N, Coales Karen, Muliyala Krishna Prasad, Chaturvedi Santosh K, Murthy Pratima, Siddiqi Najma

机构信息

National Institute of Mental Health and Neuro Sciences, Bangalore, India.

Jindal School of Psychology and Counselling, O P Jindal Global University, Sonipat, India.

出版信息

JMIR Res Protoc. 2023 Nov 16;12:e41127. doi: 10.2196/41127.

DOI:10.2196/41127
PMID:37971791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10690525/
Abstract

BACKGROUND

The increasing burden of depression and noncommunicable disease (NCD) is a global challenge, especially in low- and middle-income countries, considering the resource constraints and lack of trained human resources in these settings. Effective treatment of depression in people with NCDs has the potential to enhance both the mental and physical well-being of this population. It will also result in the effective use of the available health care resources. Brief psychological therapies, such as behavioral activation (BA), are effective for the treatment of depression. BA has not been adapted in the community health care services of India, and the feasibility of using BA as an intervention for depression in NCD and its effectiveness in these settings have not been systematically evaluated.

OBJECTIVE

Our objective is to adapt BA for the Indian NCD context and test the acceptability, feasibility, and implementation of the adapted BA intervention (BEACON intervention package [BIP]). Additionally, we aim to test the feasibility of a randomized controlled trial evaluation of BIP for the treatment of depression compared with enhanced usual care.

METHODS

Following well-established frameworks for intervention adaptation, we first adapted BA (to fit the linguistic, cultural, and resource context) for delivery in India. The intervention was also adapted for potential remote delivery by telephone. In a randomized controlled trial, we will be testing the acceptability, feasibility, and implementation of the adapted BA intervention (BIP). We shall also test if a randomized controlled feasibility trial can be delivered effectively and estimate important parameters (eg, recruitment and retention rates and completeness of follow-up) needed to design a future definitive trial.

RESULTS

Following the receipt of approval from all the relevant agencies, the development of the BIP was started on November 28, 2020, and completed on August 18, 2021, and the quantitative data collection was started on August 23, 2021, and completed on December 10, 2021. Process evaluation (qualitative data) collection is ongoing. Both the qualitative and quantitative data analyses are ongoing.

CONCLUSIONS

This study may offer insights that could help in closing the gap in the treatment of common mental illness, particularly in nations with limited resources, infrastructure, and systems such as India. To close this gap, BEACON tries to provide BA for depression in NCDs through qualified NCD (BA) counselors integrated within the state-run NCD clinics. The results of this study may aid in understanding whether BA as an intervention is acceptable for the population and how feasible it will be to deliver such interventions for depression in NCD in South Asian countries such as India. The BIP may also be used in the future by Indian community clinics as a brief intervention program.

TRIAL REGISTRATION

Clinical Trials Registry of India CTRI/2020/05/025048; https://tinyurl.com/mpt33jv5.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/41127.

摘要

背景

抑郁症和非传染性疾病(NCD)的负担日益加重,这是一个全球性挑战,尤其是在低收入和中等收入国家,因为这些地区资源有限且缺乏训练有素的人力资源。有效治疗非传染性疾病患者的抑郁症有可能改善这一人群的身心健康。这也将实现现有医疗资源的有效利用。简短心理疗法,如行为激活(BA),对抑郁症治疗有效。BA尚未在印度社区医疗服务中应用,且尚未系统评估将BA用作非传染性疾病抑郁症干预措施的可行性及其在这些环境中的有效性。

目的

我们的目标是使BA适用于印度非传染性疾病的情况,并测试改编后的BA干预措施(灯塔干预包 [BIP])的可接受性、可行性和实施情况。此外,我们旨在测试与强化常规护理相比,对BIP治疗抑郁症进行随机对照试验评估的可行性。

方法

遵循成熟的干预措施改编框架,我们首先对BA进行改编(以适应语言、文化和资源背景)以便在印度实施。该干预措施还针对通过电话进行潜在远程实施进行了改编。在一项随机对照试验中,我们将测试改编后的BA干预措施(BIP)的可接受性、可行性和实施情况。我们还将测试随机对照可行性试验能否有效开展,并估计设计未来确定性试验所需的重要参数(如招募和留存率以及随访完整性)。

结果

在获得所有相关机构的批准后,BIP的开发于2020年11月28日开始,并于2021年8月18日完成,定量数据收集于2021年8月23日开始,并于2021年12月10日完成。过程评估(定性数据)收集正在进行中。定性和定量数据分析均在进行中。

结论

本研究可能提供有助于缩小常见精神疾病治疗差距的见解,特别是在像印度这样资源、基础设施和系统有限的国家。为了缩小这一差距,灯塔项目试图通过纳入国营非传染性疾病诊所的合格非传染性疾病(BA)咨询师为非传染性疾病患者的抑郁症提供BA。本研究结果可能有助于了解BA作为一种干预措施对人群是否可接受,以及在印度等南亚国家为非传染性疾病患者的抑郁症提供此类干预措施的可行性如何。BIP未来也可能被印度社区诊所用作简短干预项目。

试验注册

印度临床试验注册中心CTRI/2020/05/025048;https://tinyurl.com/mpt33jv5。

国际注册报告识别码(IRRID):DERR1-10.2196/41127。